Patent · US Active

Beta-lactamase inhibitors

US9403850B2 · kind B2 · utility

22Cited by
5References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 10, 2014
Grant dateAug 2, 2016
Priority date—
Expiry dateJan 10, 2034

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Described herein are compounds and compositions that modulate the activity of beta-lactamases. In some embodiments, the compounds described herein inhibit beta-lactamase. In certain embodiments, the compounds described herein are useful in the treatment of bacterial infections.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.